Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1991 Apr;54(4):305–309. doi: 10.1136/jnnp.54.4.305

The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study.

Y M Hart 1, H Meinardi 1, J W Sander 1, D J Nutt 1, S D Shorvon 1
PMCID: PMC488483  PMID: 1647443

Abstract

The effect on interictal electroencephalographic epileptic activity of intravenous flumazenil (Ro 15-1788), a benzodiazepine antagonist and potential antiepileptic drug, was studied in 10 patients. Comparison was made with intravenous diazepam (10 mg) and placebo using a single-blind, single-dose, cross-over design. A dose of 3 mg flumazenil was well tolerated and produced a significantly greater reduction in the number of epileptic transients during the first 40 minutes after injection than did placebo (p less than 0.05). This effect was similar to that of diazepam in magnitude and duration. When flumazenil (3 mg) was administered immediately after intravenous diazepam (10 mg), the reduction in interictal epileptic activity was not significantly different from that produced by diazepam alone. The results suggest that either flumazenil has intrinsic antiepileptic activity and in this respect acts as a partial agonist at the benzodiazepine receptor, or that it is antagonising an endogenous proconvulsant ligand in these patients.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbaccia M. L., Costa E., Ferrero P., Guidotti A., Roy A., Sunderland T., Pickar D., Paul S. M., Goodwin F. K. Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease. Arch Gen Psychiatry. 1986 Dec;43(12):1143–1147. doi: 10.1001/archpsyc.1986.01800120029007. [DOI] [PubMed] [Google Scholar]
  2. Binnie C. D. The use of the inter-ictal EEG in the study of antiepileptic drugs. Electroencephalogr Clin Neurophysiol Suppl. 1982;36:504–512. [PubMed] [Google Scholar]
  3. Gallager D. W., Heninger K., Heninger G. Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. Eur J Pharmacol. 1986 Dec 2;132(1):31–38. doi: 10.1016/0014-2999(86)90005-1. [DOI] [PubMed] [Google Scholar]
  4. Gallager D. W., Mallorga P., Tallman J. F. Interaction of diphenylhydantoin and benzodiazepines in the CNS. Brain Res. 1980 May 5;189(1):209–220. doi: 10.1016/0006-8993(80)90018-9. [DOI] [PubMed] [Google Scholar]
  5. Gonsalves S. F., Gallager D. W. Persistent reversal of tolerance to anticonvulsant effects and GABAergic subsensitivity by a single exposure to benzodiazepine antagonist during chronic benzodiazepine administration. J Pharmacol Exp Ther. 1988 Jan;244(1):79–83. [PubMed] [Google Scholar]
  6. Gotman J., Marciani M. G. Electroencephalographic spiking activity, drug levels, and seizure occurrence in epileptic patients. Ann Neurol. 1985 Jun;17(6):597–603. doi: 10.1002/ana.410170612. [DOI] [PubMed] [Google Scholar]
  7. Guidotti A., Forchetti C. M., Corda M. G., Konkel D., Bennett C. D., Costa E. Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3531–3535. doi: 10.1073/pnas.80.11.3531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Haefely W. Endogenous ligands of the benzodiazepine receptor. Pharmacopsychiatry. 1988 Jan;21(1):43–46. doi: 10.1055/s-2007-1014645. [DOI] [PubMed] [Google Scholar]
  9. Little H. J., Nutt D. J., Taylor S. C. Bidirectional effects of chronic treatment with agonists and inverse agonists at the benzodiazepine receptor. Brain Res Bull. 1987 Sep;19(3):371–378. doi: 10.1016/0361-9230(87)90106-7. [DOI] [PubMed] [Google Scholar]
  10. Martin J. R., Pieri L., Bonetti E. P., Schaffner R., Burkard W. P., Cumin R., Haefely W. E. Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor. Pharmacopsychiatry. 1988 Nov;21(6):360–362. doi: 10.1055/s-2007-1021947. [DOI] [PubMed] [Google Scholar]
  11. Martins da Silva A., Aarts J. H., Binnie C. D., Laxminarayan R., Lopes da Silva F. H., Meijer J. W., Nagelkerke N. The circadian distribution of interictal epileptiform EEG activity. Electroencephalogr Clin Neurophysiol. 1984 Jul;58(1):1–13. doi: 10.1016/0013-4694(84)90195-0. [DOI] [PubMed] [Google Scholar]
  12. Milligan N., Dhillon S., Oxley J., Richens A. Absorption of diazepam from the rectum and its effect on interictal spikes in the EEG. Epilepsia. 1982 Jun;23(3):323–331. doi: 10.1111/j.1528-1157.1982.tb06198.x. [DOI] [PubMed] [Google Scholar]
  13. Milligan N., Oxley J., Richens A. Acute effects of intravenous phenytoin on the frequency of inter-ictal spikes in man. Br J Clin Pharmacol. 1983 Sep;16(3):285–289. doi: 10.1111/j.1365-2125.1983.tb02163.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Milligan N., Richens A. Methods of assessment of antiepileptic drugs. Br J Clin Pharmacol. 1981 May;11(5):443–456. doi: 10.1111/j.1365-2125.1981.tb01149.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Möhler H., Richards J. G. The benzodiazepine receptor: a pharmacological control element of brain function. Eur J Anaesthesiol Suppl. 1988;2:15–24. [PubMed] [Google Scholar]
  16. Nutt D. J., Cowen P. J., Little H. J. Unusual interactions of benzodiazepine receptor antagonists. Nature. 1982 Feb 4;295(5848):436–438. doi: 10.1038/295436a0. [DOI] [PubMed] [Google Scholar]
  17. Nutt D. J., Little H. J., Taylor S. C., Minchin M. C. Investigating benzodiazepine receptor function in vivo using an intravenous infusion of DMCM. Eur J Pharmacol. 1984 Aug 17;103(3-4):359–362. doi: 10.1016/0014-2999(84)90500-4. [DOI] [PubMed] [Google Scholar]
  18. Olsen R. W. GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem. 1981 Jul;37(1):1–13. doi: 10.1111/j.1471-4159.1981.tb05284.x. [DOI] [PubMed] [Google Scholar]
  19. Petursson H., Bhattacharya S. K., Glover V., Sandler M., Lader M. H. Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br J Psychiatry. 1982 Jan;140:7–10. doi: 10.1192/bjp.140.1.7. [DOI] [PubMed] [Google Scholar]
  20. Sangameswaran L., Fales H. M., Friedrich P., De Blas A. L. Purification of a benzodiazepine from bovine brain and detection of benzodiazepine-like immunoreactivity in human brain. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9236–9240. doi: 10.1073/pnas.83.23.9236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scollo-Lavizzari G. The anticonvulsant effect of the benzodiazepine antagonist, Ro 15-1788: an EEG study in 4 cases. Eur Neurol. 1984;23(1):1–6. doi: 10.1159/000115669. [DOI] [PubMed] [Google Scholar]
  22. Ticku M. K., Davis W. C. Effect of valproic acid on [3H]diazepam and [3H]dihydropicrotoxinin binding sites at the benzodiazepine-GABA receptor-ionophore complex. Brain Res. 1981 Oct 26;223(1):218–222. doi: 10.1016/0006-8993(81)90828-3. [DOI] [PubMed] [Google Scholar]
  23. Villarreal H. J., Wilder B. J., Willmore L. J., Bauman A. W., Hammond E. J., Bruni J. Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology. 1978 Sep;28(9 Pt 1):886–891. doi: 10.1212/wnl.28.9.886. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES